Longitudinal alterations in health-related quality of life and its impact on the clinical course of patients with advanced hepatocellular carcinoma receiving sorafenib treatment
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Longitudinal alterations in health-related quality of life and its impact on the clinical course of patients with advanced hepatocellular carcinoma receiving sorafenib treatment
Authors
Keywords
Advanced hepatocellular carcinoma, Sorafenib, Health-related quality of life, Clinical course, Prognostic marker
Journal
BMC CANCER
Volume 16, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-11-11
DOI
10.1186/s12885-016-2908-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Depression and Frailty in Patients With End-Stage Liver Disease Referred for Transplant Evaluation
- (2016) D. C. Cron et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma
- (2016) Fabio Farinati et al. PLOS MEDICINE
- Health-related quality of life impact in a randomised phase III study of the combination of dabrafenib and trametinib versus dabrafenib monotherapy in patients with BRAF V600 metastatic melanoma
- (2015) Dirk Schadendorf et al. EUROPEAN JOURNAL OF CANCER
- Frail phenotype and mortality prediction: A systematic review and meta-analysis of prospective cohort studies
- (2015) Shu-Fang Chang et al. INTERNATIONAL JOURNAL OF NURSING STUDIES
- Different Survival of Barcelona Clinic Liver Cancer Stage C Hepatocellular Carcinoma Patients by the Extent of Portal Vein Invasion and the Type of Extrahepatic Spread
- (2015) Dong Hyun Sinn et al. PLoS One
- Frailty Predicts Waitlist Mortality in Liver Transplant Candidates
- (2014) J. C. Lai et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Health-related quality of life as a prognostic factor in patients with advanced cancer
- (2014) Jennifer L. Steel et al. CANCER
- Associations of daily walking and television viewing time with liver cancer mortality: findings from the Japan Collaborative Cohort Study
- (2014) Shigekazu Ukawa et al. CANCER CAUSES & CONTROL
- Symptoms from treatment with sunitinib or sorafenib: a multicenter explorative cohort study to explore the influence of patient-reported outcomes on therapy decisions
- (2014) J. J. Koldenhof et al. SUPPORTIVE CARE IN CANCER
- The association between frequency of vigorous physical activity and hepatobiliary cancers in the NIH-AARP Diet and Health Study
- (2013) Gundula Behrens et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Sorafenib in Elderly Patients with Advanced Hepatocellular Carcinoma: A Case Series
- (2013) Liliana Montella et al. ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2012) Bassam Estfan et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- The added value of quality of life (QoL) for prognosis of overall survival in patients with palliative hepatocellular carcinoma
- (2012) Momar Diouf et al. JOURNAL OF HEPATOLOGY
- Hepatocellular carcinoma
- (2012) Alejandro Forner et al. LANCET
- Sorafenib in hepatocellular carcinoma: prospective study on adverse events, quality of life, and related feasibility under daily conditions
- (2012) Paola Rita Brunocilla et al. MEDICAL ONCOLOGY
- Diarrhea Is a Positive Outcome Predictor for Sorafenib Treatment of Advanced Hepatocellular Carcinoma
- (2012) Ronald Koschny et al. ONCOLOGY
- Quality of life assessment as a predictor of survival in non-small cell lung cancer
- (2011) Donald P Braun et al. BMC CANCER
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Can changes in health related quality of life scores predict survival in stages III and IV colorectal cancer?
- (2011) Donald P Braun et al. Health and Quality of Life Outcomes
- Impact of sorafenib on health-related quality of life in Japanese patients with metastatic renal cell carcinoma: a prospective evaluation
- (2010) Hideaki Miyake et al. BJU INTERNATIONAL
- Trajectories of Disability in the Last Year of Life
- (2010) Thomas M. Gill et al. NEW ENGLAND JOURNAL OF MEDICINE
- Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
- (2010) Riccardo Lencioni et al. SEMINARS IN LIVER DISEASE
- Comparison and Improvement of MELD and Child-Pugh Score Accuracies for the Prediction of 6-month Mortality in Cirrhotic Patients
- (2009) Jérôme Boursier et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Molecular Targeted Therapies for Solid Tumors: Management of Side Effects
- (2009) Viktor Grünwald et al. Oncology Research and Treatment
- Health-related quality of life during treatment for renal cell carcinoma: results from a phase II study of axitinib
- (2008) Peter C. Trask et al. ACTA ONCOLOGICA
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now